Meet Mikel Etchegaray, M.D.
Mikel Etchegaray, MD
Department of Hospital Medicine, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Assistant Professor, Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2015 | Tufts School of Medicine, Boston, Massachusetts, US, MD |
| 2015 | Brandeis Heller School of Business, Waltham, Massachusetts, US, Business Administration, MBA |
| 2009 | Hamilton College, Clinton, New York, US, Neuroscience, BA |
| 2009 | Hamilton College, Clinton, New York, US, Functional Characterization of DBHr by Cloning, Senior Thesis |
Postgraduate Training
| 2015-2018 | Clinical Residency, Internal Medicine, Baylor College of Medicine, Houston, Texas |
Licenses & Certifications
| 2026 | DEA |
| 2024 | BLS |
| 2024 | ACLS |
| 2018 | American Board of Internal Medicine |
| 2017 | Texas Medical License |
Experience & Service
Faculty Academic Appointments
Assistant Professor, Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021
Instructor, General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - 2021
Other Professional Positions
Consultant, Johnson & Johnson, Emerging Technologies Department, Boston, MA, 2011 - 2012
Consultant, Cambridge Health Alliance, Public Health Department, Boston, MA, 2011 - 2011
Dyslexia Lab: Research Assistant, Beth Israel Deaconess Medical Center, Boston, MA, 2009 - 2011
National Institute on Drug Abuse: Summer Student Research, National Institutes of Health, Baltimore, MD, 2008 - 2008
Mechanisms of Behavior: Summer Student Researcher, Duke University, Durham, SC, 2007 - 2007
Honors & Awards
| 2018 - 2023 | Best Teaching Attending Award for Inpatient Services, UT MD Anderson Cancer Center |
| 2016 | Best Outpatient Residency, Baylor College of Medicine, Internal Medicine Residency |
Selected Presentations & Talks
Local Presentations
- 2021. N/A. Conference. Baylor College of Medicine Grand Rounds. Houston, TX, US.
Selected Publications
Peer-Reviewed Articles
- Manzano JM, Muthu M, Kheder E, Mohammed A, Halm J, Dickson K, Ali N, Leung C, Koom-Dadzie K, Rubio D, Odaro O, Sibille M, Etchegaray M, Wilson K, Lin H, George M. Hospitalization characteristics and outcomes of patients with cancer and COVID-19 at a comprehensive cancer center. Support Care Cancer 30(9):7783-7788, 2022. e-Pub 2022. PMID: 35705751.
- Lai KA, Sheshadri A, Adrianza AM, Etchegaray M, Balachandran DD, Bashoura L, Shannon VR, Faiz SA. Role of Infliximab in Immune Checkpoint Inhibitor Induced Pneumonitis. J Immunother Precis Oncol 3(4):172-174, 2020. e-Pub 2020. PMID: 35665375.
- Jeyakumar N, Etchegaray M, Henry J, Lelenwa L, Zhao B, Segura A, Buja LM. A Case Report of Myasthenia Gravis, 2020. e-Pub 2020.
- Jeyakumar N, Etchegaray M, Henry J, Lelenwa L, Zhao B, Segura A, Buja LM. The Terrible Triad of Checkpoint Inhibition: A Case Report of Myasthenia Gravis, Myocarditis, and Myositis Induced by Cemiplimab in a Patient with Metastatic Cutaneous Squamous Cell Carcinoma. Case Reports Immunol 2020:5126717, 2020. e-Pub 2020. PMID: 32695533.
- Adler WT, Platt MP, Mehlhorn AJ, Haight JL, Currier TA, Etchegaray M, Galaburda AM, Rosen GD. Position of neocortical neurons transfected at different gestational ages with shRNA targeted against candidate dyslexia susceptibility genes. PLoS One 8(5):e65179, 2013. e-Pub 2013. PMID: 23724130.
- Currier TA, Etchegaray M, Haight JL, Galaburda AM, Rosen GD. The effects of embryonic knockdown of the candidate dyslexia susceptibility gene homologue Dyx1c1 on the distribution of GABAergic neurons in the cerebral cortex. Neuroscience 172:535-46, 2011. e-Pub 2011. PMID: 21070838.
- Cheng RK, Etchegaray M, Meck WH. Impairments in timing, temporal memory, and reversal learning linked to neurotoxic regimens of methamphetamine intoxication. Brain Res 1186:255-66, 2007. e-Pub 2007. PMID: 17996849.
- Glombicki SE, MD MBA, Matin S, MD, Muzzafar T, MD, Etchegaray M, MD, Garnes ND, MD, Rojas-Hernandez CM, MD. A Case Report of Acquired Thrombocytopenia and Neutropenia after Intrarenal BCG Immunotherapy Treatment for Urothelial Carcinoma of the Kidney.
Review Articles
- Williamson LL, Cheng RK, Etchegaray M, Meck WH. "Speed" warps time: methamphetamine's interactive roles in drug abuse, habit formation, and the biological clocks of circadian and interval timing. Curr Drug Abuse Rev 1(2):203-12, 2008. e-Pub 2008. PMID: 19630719.
Patient Reviews
CV information above last modified September 10, 2026